INNOVACAP

Innova Captab Share Price

₹784.15 -27.3 (-3.36%)

22 Feb, 2025 21:27

SIP TrendupStart SIP in INNOVACAP

Start SIP

Performance

  • Low
  • ₹776
  • High
  • ₹834
  • 52 Week Low
  • ₹421
  • 52 Week High
  • ₹1,260
  • Open Price₹830
  • Previous Close₹811
  • Volume79,679

Investment Returns

  • Over 1 Month -24.32%
  • Over 3 Month -19.06%
  • Over 6 Month + 15.65%
  • Over 1 Year + 50.15%
SIP Lightning

Smart Investing Starts Here Start SIP with Innova Captab for Steady Growth!

Invest Now

Innova Captab Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 35.2
  • PEG Ratio
  • 0.7
  • Market Cap Cr
  • 4,487
  • P/B Ratio
  • 5
  • Average True Range
  • 54.92
  • EPS
  • 22.26
  • Dividend Yield
  • 0
  • MACD Signal
  • -51.85
  • RSI
  • 32.84
  • MFI
  • 22.18

Innova Captab Financials

Innova Captab Technicals

EMA & SMA

Current Price
₹784.15
-27.3 (-3.36%)
pointer
  • stock-down_img
  • Bearish Moving Average 15
  • stock-up_img
  • Bullish Moving Average 1
  • 20 Day
  • ₹882.08
  • 50 Day
  • ₹941.10
  • 100 Day
  • ₹913.31
  • 200 Day
  • ₹801.61

Resistance and Support

798.03 Pivot Speed
  • R3 879.52
  • R2 856.98
  • R1 820.57
  • S1 761.62
  • S2 739.08
  • S3 702.67

What's your outlook on Innova Captab?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Innova Captab Ltd. is a leading pharmaceutical company in India, specializing in the manufacturing of formulations, including tablets, capsules, and syrups. It caters to domestic and international markets with a focus on quality and innovation.

Innova Captab Ltd has an operating revenue of Rs. 1,191.57 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of 12% is healthy, ROE of 11% is good. The company has a reasonable debt to equity of 25%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 5% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 45 which is a POOR score indicating inconsistency in earnings, a RS Rating of 84 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 67 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock has some strength but we want to see some buyer interest and further fundamental performance to qualify as a growth stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Innova Captab Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-05 Quarterly Results & Others To consider other business matters.
2024-11-07 Quarterly Results
2024-08-09 Quarterly Results
2024-05-29 Audited Results
2024-02-13 Quarterly Results

Innova Captab F&O

Innova Captab Shareholding Pattern

50.9%
11.03%
1.67%
0.74%
26.96%
8.7%

About Innova Captab

  • NSE Symbol
  • INNOVACAP
  • BSE Symbol
  • 544067
  • Managing Director
  • Mr. Vinay Kumar Lohariwala
  • ISIN
  • INE0DUT01020

Similar Stocks to Innova Captab

Innova Captab FAQs

Innova Captab share price is ₹784 As on 22 February, 2025 | 21:13

The Market Cap of Innova Captab is ₹4487.3 Cr As on 22 February, 2025 | 21:13

The P/E ratio of Innova Captab is 35.2 As on 22 February, 2025 | 21:13

The PB ratio of Innova Captab is 5 As on 22 February, 2025 | 21:13

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23